Endovascular Therapy Versus Open Surgery for Common Femoral Artery Atherosclerotic Occlusive Disease: A Systematic

Chuwen Chen1, Yiyuan Li1, Jing Hu2

  • 1Division of Vascular Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Insights

Endovascular therapy (EVT) for common femoral artery disease reduces early complications and hospital stays compared to open surgery (OS). However, open surgery offers more durable patency and fewer reinterventions, necessitating individualized treatment strategies.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Cardiovascular Disease

Background:

  • Optimal revascularization for common femoral artery (CFA) atherosclerotic occlusive disease is debated.
  • Comparing endovascular therapy (EVT) and open surgery (OS) is crucial for treatment decisions.

Purpose of the Study:

  • To systematically review and meta-analyze perioperative and long-term outcomes of EVT versus OS for CFA atherosclerotic occlusive disease.
  • To compare key clinical endpoints including morbidity, patency, reintervention, and survival.

Main Methods:

  • Systematic review and meta-analysis of comparative studies.
  • Searched PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov.
  • Pooled time-to-event data as hazard ratios (HRs) and assessed risk of bias and evidence certainty.

Main Results:

  • EVT reduced 30-day morbidity, wound complications, and hospital stay compared to OS.
  • EVT increased distal embolization and follow-up major amputation rates.
  • OS demonstrated more durable patency and lower reintervention rates, though amputation-free survival was similar.

Conclusions:

  • EVT offers advantages in early recovery and reduced complications.
  • OS provides superior long-term patency and fewer reinterventions.
  • Individualized treatment is recommended due to heterogeneous and observational evidence.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...